Paulo Naud

9.1k total citations · 1 hit paper
49 papers, 2.7k citations indexed

About

Paulo Naud is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Paulo Naud has authored 49 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 12 papers in Surgery and 12 papers in Oncology. Recurrent topics in Paulo Naud's work include Cervical Cancer and HPV Research (41 papers), Hepatitis B Virus Studies (14 papers) and Genital Health and Disease (12 papers). Paulo Naud is often cited by papers focused on Cervical Cancer and HPV Research (41 papers), Hepatitis B Virus Studies (14 papers) and Genital Health and Disease (12 papers). Paulo Naud collaborates with scholars based in Brazil, Finland and Portugal. Paulo Naud's co-authors include Cecília Roteli-Martins, Júlio César Teixeira, Toufik Zahaf, Newton Sérgio de Carvalho, Anne Schuind, Eduardo L. Franco, Diane M. Harper, Gary Dubin, Wim Quint and Cosette M. Wheeler and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Paulo Naud

45 papers receiving 2.5k citations

Hit Papers

Efficacy of a bivalent L1 virus-like particle vaccine in ... 2004 2026 2011 2018 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
    2004 1.2k citations Diane M. Harper, Eduardo L. Franco et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paulo Naud Brazil 20 2.2k 812 554 456 281 49 2.7k
Júlio César Teixeira Brazil 18 1.9k 0.9× 750 0.9× 450 0.8× 335 0.7× 209 0.7× 69 2.4k
Ana Cecilia Rodríguez United States 25 2.5k 1.1× 1.0k 1.3× 673 1.2× 380 0.8× 355 1.3× 39 3.1k
Frances B. Alvarez United States 8 1.8k 0.8× 648 0.8× 482 0.9× 299 0.7× 176 0.6× 8 2.1k
Newton Sérgio de Carvalho Brazil 16 1.6k 0.7× 593 0.7× 422 0.8× 211 0.5× 212 0.8× 77 2.2k
Cecília Roteli-Martins Brazil 22 3.4k 1.5× 1.3k 1.6× 739 1.3× 568 1.2× 364 1.3× 67 3.9k
Carolina Porras United States 31 3.1k 1.4× 1.3k 1.6× 675 1.2× 453 1.0× 579 2.1× 77 3.9k
Alison Fiander United Kingdom 27 1.7k 0.8× 620 0.8× 841 1.5× 387 0.8× 352 1.3× 95 2.5k
John Schussler United States 19 1.9k 0.8× 794 1.0× 202 0.4× 327 0.7× 301 1.1× 35 2.0k
Joseph Monsonégo France 22 2.2k 1.0× 1.0k 1.3× 166 0.3× 468 1.0× 348 1.2× 70 2.5k
Heather Cubie United Kingdom 33 3.1k 1.4× 1.2k 1.5× 250 0.5× 660 1.4× 633 2.3× 104 3.6k

Countries citing papers authored by Paulo Naud

Since Specialization
Citations

This map shows the geographic impact of Paulo Naud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulo Naud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulo Naud more than expected).

Fields of papers citing papers by Paulo Naud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paulo Naud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulo Naud. The network helps show where Paulo Naud may publish in the future.

Co-authorship network of co-authors of Paulo Naud

This figure shows the co-authorship network connecting the top 25 collaborators of Paulo Naud. A scholar is included among the top collaborators of Paulo Naud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paulo Naud. Paulo Naud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naud, Paulo, et al.. (2022). Evaluation of cervical cancer screening programs in the State of Rio Grande do Sul - Southern Brazil. SHILAP Revista de lepidopterología.
2.
Ramanakumar, Agnihotram V., Paulo Naud, Cecília Roteli-Martins, et al.. (2016). Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial. BMJ Open. 6(8). e011371–e011371. 27 indexed citations
3.
Syrjänen, Stina, Luı́s Otávio Sarian, Paulo Naud, et al.. (2013). Competing-Risks Regression Models in Analysis of Biomarkers as Predictors of High-risk Human Papillomavirus (HPV) Infection Outcomes and Incident CIN in the LAMS Cohort. International Journal of Gynecological Pathology. 32(4). 406–415. 1 indexed citations
4.
Vettorazzi, Janete, et al.. (2012). Prevalência e seguimento de exame citopatológico de colo uterino com atipias em células escamosas de origem indeterminada em um hospital universitário brasileiro. SHILAP Revista de lepidopterología.
5.
Roteli-Martins, Cecília, Newton Sérgio de Carvalho, Paulo Naud, et al.. (2011). Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States. International Journal of Gynecological Pathology. 0(0). 173–184. 29 indexed citations
6.
Sankaranarayanan, Rengaswamy, Catherine Sauvaget, Kunnambath Ramadas, et al.. (2011). Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Annals of Oncology. 22. vii20–vii28. 19 indexed citations
7.
Syrjänen, Stina, Paulo Naud, Luı́s Otávio Sarian, et al.. (2010). Up-regulation of Lipocalin 2 Is Associated With High-Risk Human Papillomavirus and Grade of Cervical Lesion at Baseline but Does Not Predict Outcomes of Infections or Incident Cervical Intraepithelial Neoplasia. American Journal of Clinical Pathology. 134(1). 50–59. 11 indexed citations
8.
Syrjänen, Stina, Paulo Naud, Luı́s Otávio Sarian, et al.. (2010). p300 Expression is Related to High-risk Human Papillomavirus Infections and Severity of Cervical Intraepithelial Neoplasia But Not to Viral or Disease Outcomes in a Longitudinal Setting. International Journal of Gynecological Pathology. 29(2). 135–145. 3 indexed citations
9.
Borba, Paola Colares de, et al.. (2010). O que falta na luta contra o câncer de colo uterino. 15(4). 1 indexed citations
10.
Hammes, Luciano Serpa, et al.. (2009). Reconhecimento pela Descoberta do Papilomavírus Humano (HPV). SHILAP Revista de lepidopterología.
11.
Sarian, Luı́s Otávio, Luciano Serpa Hammes, Adhemar Longatto‐Filho, et al.. (2009). Increased Risk of Oncogenic Human Papillomavirus Infections and Incident High-Grade Cervical Intraepithelial Neoplasia Among Smokers. Sexually Transmitted Diseases. 36(4). 241–248. 22 indexed citations
12.
Syrjänen, Stina, Paulo Naud, Luı́s Otávio Sarian, et al.. (2009). Up-Regulation of Plasminogen Activator Inhibitor-2 Is Associated With High-Risk HPV and Grade of Cervical Lesion at Baseline but Does Not Predict Outcomes of High-Risk HPV Infections or Incident CIN. American Journal of Clinical Pathology. 132(6). 883–892. 5 indexed citations
13.
Roteli-Martins, Cecília, Adhemar Longatto‐Filho, L S Hammes, et al.. (2007). Association Between Age At First Sexual Intercourse And Subsequent Human Papillomavirus Infection: Results Of A Brazilian Screening Program [associação Entre Idade Ao Início Da Atividade Sexual E Subsequente Infecção Por Papilomavírus Humano: Resultados De Um Programa De Rastreamento Brasileiro]. Scopus. 1 indexed citations
14.
Gall, Stanley A., Júlio César Teixeira, Cosette M. Wheeler, et al.. (2007). Substantial impact on precancerous lesions and HPV infections through 5.5 years in women vaccinated with the HPV-16/18 L1 VLP AS04 candidate vaccine. Cancer Research. 67. 4900–4900. 31 indexed citations
15.
Longatto‐Filho, Adhemar, Mojca Eržen, M Branca, et al.. (2006). Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study. International Journal of Gynecological Cancer. 16(3). 955–962. 26 indexed citations
16.
Harper, Diane M., Eduardo L. Franco, Cosette M. Wheeler, et al.. (2005). Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized, Controlled Trial. Obstetrical & Gynecological Survey. 60(5). 303–305. 12 indexed citations
17.
Harper, Diane M., Eduardo L. Franco, Cosette M. Wheeler, et al.. (2005). Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial. Obstetrical & Gynecological Survey. 60(3). 171–173. 205 indexed citations
18.
Syrjänen, Karí, Paulo Naud, Sophie Derchain, et al.. (2005). Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.. PubMed. 25(5). 3469–80. 57 indexed citations
19.
Longatto‐Filho, Adhemar, Mojca Eržen, Margherita Branca, et al.. (2005). Conventional Pap Smear and Liquid-Based Cytology as Screening Tools in Low-Resource Settings in Latin America. Acta Cytologica. 49(5). 500–506. 26 indexed citations
20.
Naud, Paulo, et al.. (2003). Efficacy and tolerability of fenticonazole for the treatment of bacterial vaginosis - a prospective double-blind, randomized, controlled and placebo-compared study. RBM. Revista brasileira de medicina. 60. 67–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Júlio César Teixeira Breakdown of academic impact, for papers by Ana Cecilia Rodríguez Breakdown of academic impact, for papers by Frances B. Alvarez Breakdown of academic impact, for papers by Newton Sérgio de Carvalho Breakdown of academic impact, for papers by Cecília Roteli-Martins Breakdown of academic impact, for papers by Carolina Porras Breakdown of academic impact, for papers by Alison Fiander Breakdown of academic impact, for papers by John Schussler Breakdown of academic impact, for papers by Joseph Monsonégo Breakdown of academic impact, for papers by Heather Cubie
Rankless by CCL
2026